The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease

doi:10.1084/jem.179.1.185

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Reddehase, M. J.
	Articles by Koszinowski, U. H.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Reddehase, M. J.
	Articles by Koszinowski, U. H.


Social Bookmarking

	What's this?

ARTICLES

The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease

MJ Reddehase, M Balthesen, M Rapp, S Jonjic, I Pavic and UH Koszinowski
Department of Virology, University of Ulm, Germany.

Recurrence of cytomegalovirus (CMV) from latency is a frequent cause of disease in immunocompromised patients. To date, there is no explanation for the diversity in the clinical manifestations. Primary infection can occur perinatally or later in life, and inevitably results in latent infection. Seropositivity for antibodies against CMV is indicative of latent infection, but is insufficient as a predictor for the risk of recurrence. As a model for this important medical problem, we compared the risks of murine CMV recurrence from latency established after neonatal primary infection and after infection at adult age. The risk of CMV recurrence was high only after neonatal infection. The copy number of latent viral genome in tissues was identified as the key parameter that determines the overall and organ-specific risks of recurrence. Latent CMV burden and risk of recurrence were related to the extent of virus multiplication during primary infection. The presence of latent CMV in multiple organs provides the molecular basis for stochastic events of recurrence in single organs or in any combination thereof. These findings are discussed as a concept of multifocal CMV latency and recurrence. It provides a rationale for the diversity in the clinical outcome of CMV disease.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Gustems, M., Busche, A., Messerle, M., Ghazal, P., Angulo, A. (2008). In Vivo Competence of Murine Cytomegalovirus under the Control of the Human Cytomegalovirus Major Immediate-Early Enhancer in the Establishment of Latency and Reactivation. J. Virol. 82: 10302-10307 [Abstract] [Full Text]
Bantug, G. R. B., Cekinovic, D., Bradford, R., Koontz, T., Jonjic, S., Britt, W. J. (2008). CD8+ T Lymphocytes Control Murine Cytomegalovirus Replication in the Central Nervous System of Newborn Animals. J. Immunol. 181: 2111-2123 [Abstract] [Full Text]
Klenovsek, K., Weisel, F., Schneider, A., Appelt, U., Jonjic, S., Messerle, M., Bradel-Tretheway, B., Winkler, T. H., Mach, M. (2007). Protection from CMV infection in immunodeficient hosts by adoptive transfer of memory B cells. Blood 110: 3472-3479 [Abstract] [Full Text]
Belnoue, E., Fontannaz-Bozzotti, P., Grillet, S., Lambert, P.-H., Siegrist, C.-A. (2007). Protracted Course of Lymphocytic Choriomeningitis Virus WE Infection in Early Life: Induction but Limited Expansion of CD8+ Effector T Cells and Absence of Memory CD8+ T Cells. J. Virol. 81: 7338-7350 [Abstract] [Full Text]
Humphreys, I. R., de Trez, C., Kinkade, A., Benedict, C. A., Croft, M., Ware, C. F. (2007). Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands. JEM 204: 1217-1225 [Abstract] [Full Text]
Bozza, S., Bistoni, F., Gaziano, R., Pitzurra, L., Zelante, T., Bonifazi, P., Perruccio, K., Bellocchio, S., Neri, M., Iorio, A. M., Salvatori, G., De Santis, R., Calvitti, M., Doni, A., Garlanda, C., Mantovani, A., Romani, L. (2006). Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood 108: 3387-3396 [Abstract] [Full Text]
Simon, C. O., Holtappels, R., Tervo, H.-M., Bohm, V., Daubner, T., Oehrlein-Karpi, S. A., Kuhnapfel, B., Renzaho, A., Strand, D., Podlech, J., Reddehase, M. J., Grzimek, N. K. A. (2006). CD8 T Cells Control Cytomegalovirus Latency by Epitope-Specific Sensing of Transcriptional Reactivation. J. Virol. 80: 10436-10456 [Abstract] [Full Text]
Ghazal, P., Visser, A. E., Gustems, M., Garcia, R., Borst, E. M., Sullivan, K., Messerle, M., Angulo, A. (2005). Elimination of ie1 Significantly Attenuates Murine Cytomegalovirus Virulence but Does Not Alter Replicative Capacity in Cell Culture. J. Virol. 79: 7182-7194 [Abstract] [Full Text]
Flano, E., Jia, Q., Moore, J., Woodland, D. L., Sun, R., Blackman, M. A. (2005). Early Establishment of {gamma}-Herpesvirus Latency: Implications for Immune Control. J. Immunol. 174: 4972-4978 [Abstract] [Full Text]
Simon, C. O., Seckert, C. K., Dreis, D., Reddehase, M. J., Grzimek, N. K. A. (2005). Role for Tumor Necrosis Factor Alpha in Murine Cytomegalovirus Transcriptional Reactivation in Latently Infected Lungs. J. Virol. 79: 326-340 [Abstract] [Full Text]
Li Pira, G., Bottone, L., Ivaldi, F., Pelizzoli, R., Del Galdo, F., Lozzi, L., Bracci, L., Loregian, A., Palu, G., De Palma, R., Einsele, H., Manca, F. (2004). Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution. Int Immunol 16: 635-642 [Abstract] [Full Text]
Karrer, U., Wagner, M., Sierro, S., Oxenius, A., Hengel, H., Dumrese, T., Freigang, S., Koszinowski, U. H., Phillips, R. E., Klenerman, P. (2004). Expansion of Protective CD8+ T-Cell Responses Driven by Recombinant Cytomegaloviruses. J. Virol. 78: 2255-2264 [Abstract] [Full Text]
Tibbetts, S. A., Loh, J., van Berkel, V., McClellan, J. S., Jacoby, M. A., Kapadia, S. B., Speck, S. H., Virgin, H. W. IV (2003). Establishment and Maintenance of Gammaherpesvirus Latency Are Independent of Infective Dose and Route of Infection. J. Virol. 77: 7696-7701 [Abstract] [Full Text]
Kercher, L., Mitchell, B. M. (2002). Persisting Murine Cytomegalovirus Can Reactivate and Has Unique Transcriptional Activity in Ocular Tissue. J. Virol. 76: 9165-9175 [Abstract] [Full Text]
Tsutsui, Y., Kawasaki, H., Kosugi, I. (2002). Reactivation of Latent Cytomegalovirus Infection in Mouse Brain Cells Detected after Transfer to Brain Slice Cultures. J. Virol. 76: 7247-7254 [Abstract] [Full Text]
Holtappels, R., Grzimek, N. K. A., Simon, C. O., Thomas, D., Dreis, D., Reddehase, M. J. (2002). Processing and Presentation of Murine Cytomegalovirus pORFm164-Derived Peptide in Fibroblasts in the Face of All Viral Immunosubversive Early Gene Functions. J. Virol. 76: 6044-6053 [Abstract] [Full Text]
Morello, C. S., Ye, M., Spector, D. H. (2002). Development of a Vaccine against Murine Cytomegalovirus (MCMV), Consisting of Plasmid DNA and Formalin-Inactivated MCMV, That Provides Long-Term, Complete Protection against Viral Replication. J. Virol. 76: 4822-4835 [Abstract] [Full Text]
Sester, M., Sester, U., Gartner, B., Kubuschok, B., Girndt, M., Meyerhans, A., Kohler, H. (2002). Sustained High Frequencies of Specific CD4 T Cells Restricted to a Single Persistent Virus. J. Virol. 76: 3748-3755 [Abstract] [Full Text]
Holtappels, R., Grzimek, N. K. A., Thomas, D., Reddehase, M. J. (2002). Early gene m18, a novel player in the immune response to murine cytomegalovirus. J. Gen. Virol. 83: 311-316 [Abstract] [Full Text]
Holtappels, R., Thomas, D., Podlech, J., Reddehase, M. J. (2002). Two Antigenic Peptides from Genes m123 and m164 of Murine Cytomegalovirus Quantitatively Dominate CD8 T-Cell Memory in the H-2d Haplotype. J. Virol. 76: 151-164 [Abstract] [Full Text]
Holtappels, R., Podlech, J., Grzimek, N. K. A., Thomas, D., Pahl-Seibert, M.-F., Reddehase, M. J. (2001). Experimental Preemptive Immunotherapy of Murine Cytomegalovirus Disease with CD8 T-Cell Lines Specific for ppM83 and pM84, the Two Homologs of Human Cytomegalovirus Tegument Protein ppUL83 (pp65). J. Virol. 75: 6584-6600 [Abstract] [Full Text]
Grzimek, N. K. A., Dreis, D., Schmalz, S., Reddehase, M. J. (2001). Random, Asynchronous, and Asymmetric Transcriptional Activity of Enhancer-Flanking Major Immediate-Early Genes ie1/3 and ie2 during Murine Cytomegalovirus Latency in the Lungs. J. Virol. 75: 2692-2705 [Abstract] [Full Text]
Holtappels, R., Pahl-Seibert, M.-F., Thomas, D., Reddehase, M. J. (2000). Enrichment of Immediate-Early 1 (m123/pp89) Peptide-Specific CD8 T Cells in a Pulmonary CD62Llo Memory-Effector Cell Pool during Latent Murine Cytomegalovirus Infection of the Lungs. J. Virol. 74: 11495-11503 [Abstract] [Full Text]
Podlech, J., Holtappels, R., Pahl-Seibert, M.-F., Steffens, H.-P., Reddehase, M. J. (2000). Murine Model of Interstitial Cytomegalovirus Pneumonia in Syngeneic Bone Marrow Transplantation: Persistence of Protective Pulmonary CD8-T-Cell Infiltrates after Clearance of Acute Infection. J. Virol. 74: 7496-7507 [Abstract] [Full Text]
Hoge, A. T., Hendrickson, S. B., Burns, W. H. (2000). Murine Gammaherpesvirus 68 Cyclin D Homologue Is Required for Efficient Reactivation from Latency. J. Virol. 74: 7016-7023 [Abstract] [Full Text]
Rybak, R. J., Hartline, C. B., Qiu, Y.-L., Zemlicka, J., Harden, E., Marshall, G., Sommadossi, J.-P., Kern, E. R. (2000). In Vitro Activities of Methylenecyclopropane Analogues of Nucleosides and Their Phosphoralaninate Prodrugs against Cytomegalovirus and Other Herpesvirus Infections. Antimicrob. Agents Chemother. 44: 1506-1511 [Abstract] [Full Text]
Krmpotic, A., Messerle, M., Crnkovic-Mertens, I., Polic, B., Jonjic, S., Koszinowski, U. H. (1999). The Immunoevasive Function Encoded by the Mouse Cytomegalovirus Gene m152 Protects the Virus Against T Cell Control In Vivo. JEM 190: 1285-1296 [Abstract] [Full Text]
Kurz, S. K., Reddehase, M. J. (1999). Patchwork Pattern of Transcriptional Reactivation in the Lungs Indicates Sequential Checkpoints in the Transition from Murine Cytomegalovirus Latency to Recurrence. J. Virol. 73: 8612-8622 [Abstract] [Full Text]
Morello, C. S., Cranmer, L. D., Spector, D. H. (1999). In Vivo Replication, Latency, and Immunogenicity of Murine Cytomegalovirus Mutants with Deletions in the M83 and M84 Genes, the Putative Homologs of Human Cytomegalovirus pp65 (UL83). J. Virol. 73: 7678-7693 [Abstract] [Full Text]
Wagner, M., Koszinowski, U. H., Messerle, M. (1999). Systematic Excision of Vector Sequences from the BAC-Cloned Herpesvirus Genome during Virus Reconstitution. J. Virol. 73: 7056-7060 [Abstract] [Full Text]
Speckner, A., Glykofrydes, D., Ohlin, M., Mach, M. (1999). Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization. J. Gen. Virol. 80: 2183-2191 [Abstract] [Full Text]
Aiba-Masago, S., Baba, S., Li, R.-Y., Shinmura, Y., Kosugi, I., Arai, Y., Nishimura, M., Tsutsui, Y. (1999). Murine Cytomegalovirus Immediate-Early Promoter Directs Astrocyte-Specific Expression in Transgenic Mice. Am. J. Pathol. 154: 735-743 [Abstract] [Full Text]
Klein, M., Schoppel, K., Amvrossiadis, N., Mach, M. (1999). Strain-Specific Neutralization of Human Cytomegalovirus Isolates by Human Sera. J. Virol. 73: 878-886 [Abstract] [Full Text]
Kurz, S. K., Rapp, M., Steffens, H.-P., Grzimek, N. K.�A., Schmalz, S., Reddehase, M. J. (1999). Focal Transcriptional Activity of Murine Cytomegalovirus during Latency in the Lungs. J. Virol. 73: 482-494 [Abstract] [Full Text]
Polic, B., Hengel, H., Krmpotic, A., Trgovcich, J., Pavic, I., Lucin, P., Jonjic, S., Koszinowski, U. H. (1998). Hierarchical and Redundant Lymphocyte Subset Control Precludes Cytomegalovirus Replication during Latent Infection. JEM 188: 1047-1054 [Abstract] [Full Text]
Halwachs-Baumann, G., Wilders-Truschnig, M., Desoye, G., Hahn, T., Kiesel, L., Klingel, K., Rieger, P., Jahn, G., Sinzger, C. (1998). Human Trophoblast Cells Are Permissive to the Complete Replicative Cycle of Human Cytomegalovirus. J. Virol. 72: 7598-7602 [Abstract] [Full Text]
Steffens, H.-P., Kurz, S., Holtappels, R., Reddehase, M. J. (1998). Preemptive CD8 T-Cell Immunotherapy of Acute Cytomegalovirus Infection Prevents Lethal Disease, Limits the Burden of Latent Viral Genomes, and Reduces the Risk of Virus Recurrence. J. Virol. 72: 1797-1804 [Abstract] [Full Text]
Crnkovic-Mertens, I., Messerle, M., Szepan, U., Koszinowski, U. H. (1998). Virus Attenuation after Deletion of the Cytomegalovirus Fc Receptor Gene Is Not due to Antibody Control. J. Virol. 72: 1377-1382 [Abstract] [Full Text]
MacDonald, M. R., Li, X.-Y., Stenberg, R. M., Campbell, A. E., Virgin, H. W. IV (1998). Mucosal and Parenteral Vaccination against Acute and Latent Murine Cytomegalovirus (MCMV) Infection by Using an Attenuated MCMV Mutant. J. Virol. 72: 442-451 [Abstract] [Full Text]